IRCT20200105046010N32尚未招募未知
In- Vivo Bioequivalence study of Oxycodone tablet 40 mg Faran shimi (FAROXY® ER 40mg Tab.) with brand drugs (OXYCONTINE® ER 40 mg Tab.,Purdue Pharma LP, UK) in Iranian healthy volunteers
Pharan shimi Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
不适用
In- Vivo Bioequivalence study of Oxycodone tablet 40 mg Alborz Pharmed (LENITON® ER 40mg Tab.) with brand drugs (OLBETE® ER 40 mg Tab.,Purdue Pharma LP, UK) in Iranian healthy volunteersBio equivalence test.IRCT20200105046010N69Alborz Pharmed Pharmaceutical Co.24
进行中（未招募）
1 期
En sammenlignende undersøgelse af iv. oxycodon og iv. fentanyl i behandlingen af postoperative smerter efter laparoskopisk cholecystektomi.EUCTR2006-003267-31-DKDepartment of anesthesiology80
已完成
3 期
Comparison of the effect of oral Oxycodone versus intravenous Ketorolac on post laparoscopic cholecystectomy paiIRCT20181216041991N1Shahid Beheshti University of Medical Sciences60
已完成
1 期
A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) TabletsHealthy VolunteersNCT01099709Purdue Pharma LP85
已完成
1 期
A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) TabletsHealthy VolunteersNCT01100086Purdue Pharma LP84